Week in Review: Researchers Describe Possible COVID-19-Related Necrotic Zoster

It has been a week full of reporting on cutting edge research at Pharmacy Times with stories on how soy may improve bone cancer treatment and how coronavirus 2019 (COVID-19) may be linked to necrotic zoster. We also wrote about the ongoing debate regarding coverage for specific pre-exposure prophylaxis (PrEP) medications.

Here are the top 5 articles of the week from Pharmacy Times.

5. Soy May Help Improve Bone Cancer Treatment

Soy may help improve bone cancer treatment, according to a new study published in Acta Biomaterialia. Read more.

4. Pediatric Diabetes Complications Linked to Worse Memory, IQ

New research has found that diabetic ketoacidosis, a common complication of type 1 diabetes, is linked to lower IQ scores and worse memory in children. Read more.

3. Addressing the Debate Regarding Coverage for PrEP

Insurance companies are currently investigating the option of modifying which medications they will cover for HIV PrEP therapy, with broad implications for patient access considering the limitations of the patient populations who will be able to use one of the drugs. Read more.

2. Perennial Allergen Immunotherapy Can Improve Quality of Life

Patients with allergic rhinitis who received allergen immunotherapy exhibited a clinical improvement in symptoms compared with those who received standard pharmacotherapy alone, according to the results of a study published in International Archives of Allergy and Immunology. Read more.

1. Researchers Describe Possible COVID-19-Related Necrotic Zoster

Researchers in Italy have published a letter suggesting there may be a link between necrotic zoster and COVID-19. Read more.